255 related articles for article (PubMed ID: 21483670)
1. Spotlight on differentially expressed genes in urinary bladder cancer.
Zaravinos A; Lambrou GI; Volanis D; Delakas D; Spandidos DA
PLoS One; 2011 Apr; 6(4):e18255. PubMed ID: 21483670
[TBL] [Abstract][Full Text] [Related]
2. Identification of common differentially expressed genes in urinary bladder cancer.
Zaravinos A; Lambrou GI; Boulalas I; Delakas D; Spandidos DA
PLoS One; 2011 Apr; 6(4):e18135. PubMed ID: 21483740
[TBL] [Abstract][Full Text] [Related]
3. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
[TBL] [Abstract][Full Text] [Related]
4. DNA microarray expression profiling of bladder cancer allows identification of noninvasive diagnostic markers.
Mengual L; Burset M; Ars E; Lozano JJ; Villavicencio H; Ribal MJ; Alcaraz A
J Urol; 2009 Aug; 182(2):741-8. PubMed ID: 19539325
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in bladder cancer identifies potential therapeutic targets.
Hussain SA; Palmer DH; Syn WK; Sacco JJ; Greensmith RMD; Elmetwali T; Aachi V; Lloyd BH; Jithesh PV; Arrand J; Barton D; Ansari J; Sibson DR; James ND
Int J Oncol; 2017 Apr; 50(4):1147-1159. PubMed ID: 28259975
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
Zhang Z; Zhang G; Gao Z; Li S; Li Z; Bi J; Liu X; Li Z; Kong C
BMC Cancer; 2017 Dec; 17(1):861. PubMed ID: 29246203
[TBL] [Abstract][Full Text] [Related]
7. Identifying the mRNAs associated with Bladder cancer recurrence.
Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis Identified Key Molecular Changes in Bladder Cancer Development and Recurrence.
Chen Q; Hu J; Deng J; Fu B; Guo J
Biomed Res Int; 2019; 2019():3917982. PubMed ID: 31828101
[No Abstract] [Full Text] [Related]
9. Molecular and Bioinformatics Analyses Identify 7 Circular RNAs Involved in Regulation of Oncogenic Transformation and Cell Proliferation in Human Bladder Cancer.
Cai D; Liu Z; Kong G
Med Sci Monit; 2018 Mar; 24():1654-1661. PubMed ID: 29558461
[TBL] [Abstract][Full Text] [Related]
10. Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder Cancer.
Kang HW; Seo SP; Byun YJ; Piao XM; Kim YH; Jeong P; Ha YS; Kim WT; Kim YJ; Lee SC; Moon SK; Choi YH; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2018 Aug; 16(4):274-280. PubMed ID: 29571585
[TBL] [Abstract][Full Text] [Related]
11. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.
Modlich O; Prisack HB; Pitschke G; Ramp U; Ackermann R; Bojar H; Vögeli TA; Grimm MO
Clin Cancer Res; 2004 May; 10(10):3410-21. PubMed ID: 15161696
[TBL] [Abstract][Full Text] [Related]
12. Identification of gene expression patterns in superficial and invasive human bladder cancer.
Thykjaer T; Workman C; Kruhøffer M; Demtröder K; Wolf H; Andersen LD; Frederiksen CM; Knudsen S; Orntoft TF
Cancer Res; 2001 Mar; 61(6):2492-9. PubMed ID: 11289120
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive gene expression analysis after ERH gene knockdown in human bladder cancer T24 cell lines.
Pang K; Hao L; Shi Z; Chen B; Pang H; Dong Y; Zhang Z; Dong B; Han C
Gene; 2020 May; 738():144475. PubMed ID: 32081697
[TBL] [Abstract][Full Text] [Related]
14. Urinary exosomal mRNA as a biomarker for the diagnosis of bladder cancer.
Wang X; Song D; Zhu B; Jin Y; Cai C; Wang Z
Anticancer Drugs; 2024 Apr; 35(4):362-370. PubMed ID: 38385960
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of noninvasive primary urothelial tumours using microarrays.
Aaboe M; Marcussen N; Jensen KM; Thykjaer T; Dyrskjøt L; Orntoft TF
Br J Cancer; 2005 Nov; 93(10):1182-90. PubMed ID: 16265353
[TBL] [Abstract][Full Text] [Related]
16. MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
Uchida Y; Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Urol Oncol; 2013 Jan; 31(1):115-23. PubMed ID: 21396852
[TBL] [Abstract][Full Text] [Related]
17. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R
Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
Merdad A; Karim S; Schulten HJ; Dallol A; Buhmeida A; Al-Thubaity F; Gari MA; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
Anticancer Res; 2014 Mar; 34(3):1355-66. PubMed ID: 24596383
[TBL] [Abstract][Full Text] [Related]
19. Gene discovery in bladder cancer progression using cDNA microarrays.
Sanchez-Carbayo M; Socci ND; Lozano JJ; Li W; Charytonowicz E; Belbin TJ; Prystowsky MB; Ortiz AR; Childs G; Cordon-Cardo C
Am J Pathol; 2003 Aug; 163(2):505-16. PubMed ID: 12875971
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study.
Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
